Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004
Different effects of cox-inhibition on airway inflammation and hyperresponsiveness in mice Source: Eur Respir J 2007; 30: Suppl. 51, 713s Year: 2007
Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008
Dissociation of the effects of a steroid on inflammation compared to airway hyperresponsiveness (AHR) in a model of asthma in conscious mice Source: Eur Respir J 2001; 18: Suppl. 33, 30s Year: 2001
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008
Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 385s Year: 2002
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012
Effects of ciclesonide and fluticasone propionate on allergen-induced chronic airway inflammation and bronchial hyperreactivity in sensitized brown-Norway rats Source: Eur Respir J 2003; 22: Suppl. 45, 280s Year: 2003
Inhaled budesonide/formoterol combination therapy significantly attenuates allergen-induced increases in airway myfibroblasts Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007
Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002
Inhaled doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Influence of formoterol alone and its fixed combination with budesonide on airway responsiveness and airway inflammation induced by repeated low dose allergen challenge Source: Eur Respir J 2007; 30: Suppl. 51, 749s Year: 2007
Effects of roflumilast on early and late allergic response and airway hyperresponsiveness in Aspergillus fumigatus -sensitized mice Source: Eur Respir J 2005; 26: Suppl. 49, 214s Year: 2005
Protection against allergen-induced airway hyperresponsiveness (AHR) by olodaterol in guinea pigs is synergistically enhanced by tiotropium Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012
Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Effect of BPIFA1 replacement on allergen-induced airway hyperresponsiveness Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
The airway inflammatory response in allergic mice is downregulated by budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 265s Year: 2001
Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016